Skip to content

Calculus invests in Notify Technology  

Notify Technology, the fast-growth provider of digital workplace safety, wellbeing, environmental and governance compliance services has announced the completion of its latest funding round, raising £3.1M in new equity.  The round was led by Calculus Capital who invested £1.85M alongside the North East Venture Fund (NEVF), supported by the European Regional Development Fund and managed … Continued

Calculus fully exit Genedrive plc for an average ROI of 2.1x

Past performance is not indicative of future performance. Calculus has delivered an average ROI of 2.1x from Genedrive plc (AIM: GDR) through a number of exits in the VCT and EIS Funds. Genedrive, a company we had supported through scale-up, was founded as a contract research business (”CRO”) but refocussed as a Point of Care … Continued

Calculus invests in Destiny Pharma

Calculus VCT has invested into Destiny Pharma, a clinical phase biotechnology company dedicated to the development of novel anti-infectives with a focus on infection prevention.

Read more